-
effectivehealthcare-admin.ahrq.gov/sites/default/files/back-pain-treatment_research_executive.pdf
February 01, 2016 - Noninvasive Treatments for Low Back Pain
1
Comparative Effectiveness Review
Number 169
Noninvasive Treatments for Low Back Pain
Executive Summary
Background
Nature and Burden of Low
Back Pain
Low back pain is one of the most
frequently encountered conditions in
clinical practice. Up to 84 percent of
adults …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
December 16, 2011 - When more than one publication reports the results of a single study, we will consider the
earliest … A priori, we
will consider an I
2
value of 75 percent or greater to represent substantial heterogeneity … meta-regression analyses if the number of studies is sufficient to warrant these
analyses.
27
Factors we will consider … To determine the overall strength of evidence score, we will first consider the risk of bias
domain
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/obesity-child_disposition-comments.pdf
June 10, 2013 - Commentator &
Affiliation
Section Comment Response
53 Peer Reviewer 4 Clarity and
Usability
Consider … Thank you for your comment
57 Peer Reviewer 3 Abstract Page vi, Abstract: consider changing “Data … Did you not consider
interventions in the community setting unless
they dealt with “policy, legislative … We consider some intervention may add cost to the family when they
change their food consumption and … It is optimal to consider both statistical significance (p value<0.05) and
biologically or clinically
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
May 27, 2014 - We have realized that here is variability in how
the term of “clinician” is used; some consider
this … Did
you consider EMBASE, which overlaps with Medline, CINAHL,
and probably Cochrane, but which also … We did consider these issues carefully in the
risk of bias assessment. … goals
and now include it in the ES and Discussion
sections.
170 TEP Reviewer 3 Results Strongly consider … We consider most outcomes
included to be “patient centered”- particularly
the health and social outcomes
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-196-disposition-comments-immunotherapy-asthma.pdf
March 23, 2018 - Peer Reviewer
#3
Methods I would consider adding financial cost to the resource … We consider
adverse events presenting in up to a third
of patients as common. … Further, it is recommended that the
authors consider adding FEV1 % to Table A2, to assist readers in … Asthma
& Immunology
General
Comments
Further, Academy leadership would encourage the authors to
consider … ALA - American
Lung
Association
General
Comments
Lastly, the draft report does not consider
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
May 01, 2013 - This review does not consider questions
regarding the safety and/or effectiveness of downstream
options … Within this report we consider studies conducted in the
United Kingdom (UK) separately from those conducted … characteristics and a
simple model; future screening studies in the United
States should strongly consider
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
February 22, 2012 - the KQs, the PICOTS, and analytical frameworks, as follow:
• KQ 2 originally was intended to consider … KQs 1 and 2 will consider, respectively,
adult (age 18 years or older) patients with documented (clinical … Factors to consider for this include the following:
• Patient characteristics, including:
o Age
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
November 01, 2012 - The
EHC Program may consider a topic as adequately covered by a recent review performed or
commissioned … The EHC Program may consider expansion of the
methods for evaluation of nominations for new research
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hepatitis-c-screening_research-protocol.pdf
October 20, 2011 - inaccessible to the public, but because
the results of such analyses are not verifiable, we will consider … To determine the appropriateness of meta-analysis, we will consider the
clinical and methodological
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
November 16, 2010 - www.effectivehealthcare.ahrq.gov
Published Online: November 16, 2010
for screening for glaucoma will consider … We will also consider other measurements of visual
impairment as defined by included studies. … We will also consider a subgroup analysis of studies that include asymptomatic participants
who have … Effectiveness
Reviews,15 and recently published in the Journal of Clinical Epidemiology.16
We will consider
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
January 01, 2007 - Further research in
this area should consider:
• Subgroups of special importance, such as
individuals
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/registries-guide-2nd-edition_disposition-comments.pdf
March 03, 2010 - Source: www.effectivehealthcare.ahrq.gov
Published Online: March 3, 2010
• An important issue to consider … A white
paper may be needed to fully consider the regulatory, technical, and scientific issues
that … Similarly, issues to consider in the design and analysis of
registries are covered in Chapter 3 and … of the Challenges section discusses
representativeness in detail and explains issues/approaches to consider … However,
this may be a useful topic to consider for future papers/updates.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - The decision was made to consider
corticosteroids as a nonspecific
treatment for chronic cough if the … Consider editing this section to better highlight
the most important threats to applicability.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/child-obesity-future_research.pdf
March 31, 2010 - Anyone who makes decisions concerning the provision of clinical care
should consider this report in … They were asked
to consider to what extent having an answer to the question would improve obesity prevention … We asked the stakeholders to
consider aspects of study design and reporting that should be included … They were asked to consider to what extent having an answer to the question
would improve obesity prevention
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
February 01, 2017 - This update to the bone metastases guideline will
consider new high-quality evidence for the 8 key questions
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s116.pdf
October 01, 2007 - To illustrate this problem, consider a recent observa-
tional study that compared the risk of mortality
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/treatment-resistant-depression_research-protocol.pdf
December 09, 2009 - The EPC will consider looking at methodological
differences of the non-pharmacologic interventions ( … When comparative studies are lacking, the EPC will consider reviewing data for each non-
http://www.effectivehealthcare.ahrq.gov … more) of similar studies of factors influencing
the use of non-pharmacological treatments, we will consider
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
July 01, 2012 - strategies for each test result.
3 Assess if modeling is useful.
4 Evaluate prior modeling studies.
5 Consider … Before developing a model de novo or adapting an existing model, reviewers should consider
searching … Consider whether modeling is practically feasible in the
given time frame. … Thus, it would be reasonable to consider all direct effects of
testing as negligible when interpreting … Consider whether modeling is practically feasible in the time
frame given.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
June 12, 2013 - potential risks (especially cardiovascular disease, uterine and breast cancer) provide reason to
consider … progestin in women with an intact uterus or unopposed estrogen for women without a uterus),
they did not consider … examined by using I2, acknowledging potential limitations52; when values exceed 25 percent, we
will consider … examined by using I2,
acknowledging
potential limitations;
when values exceed 25
percent, we will
consider
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
July 01, 2016 - Treatments for Fecal Incontinence: Current State of the Evidence
Treatments for Fecal Incontinence: Current State
of the Evidence
Focus of This Summary
This is a summary of a systematic review evaluating the evidence regarding the potential benefits and adverse effects of
surgical and nonsurgical treatments for f…